What does the evidence say about Ashwagandha Sleep Randomized Trial?

The current Migaku evidence database contains 1 reusable source document for Ashwagandha Sleep Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - At week eight, SOL was significantly reduced across treatment groups, with the ARE-MLT ( p p p p p < 0.0001). [Movva N (2026); evidence level 2] - Overall, both Ashwagandha and melatonin improved sleep disturbances in adults, with combination therapy producing the most consistent and pronounced benefits. [Movva N (2026); evidence level 2] - Ashwagandha, a revered herb in Ayurvedic medicine for over 3000 years, is recognized for its potential benefits in regulating sleep and supporting overall vitality. [Movva N (2026); evidence level 2] - This study evaluated the comparative effects of Ashwagandha root extract (ARE) and melatonin (MLT) on sleep quality in adults. [Movva N (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.